To ask the Secretary of State for Health and Social Care, what guidance his Department has issued to NHS Trusts on tackling administrative barriers to access to Givinostat treatment.
ITF Pharma UK, the United Kingdom marketing authorisation holder for givinostat, is providing access to givinostat through a type of compassionate use scheme called an Early Access Programme (EAP). Under the EAP, givinostat is free to both patients taking...
Givinostat